PER-065-02已完成未知
MULTICENTRIC STUDY, RANDOM SELECTION, DOUBLE-BLIND, CROSSBREAKING, COMPARING THE EFFECT OF L-454560 AND PLACEBO IN ADULT PATIENTS WITH CHRONIC ASTHMA.
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2002年10月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The patient understands the study procedures and agrees to participate as indicated by signing the appropriate Informed Consent Document.
- •The patient has a medical history (of at least one year) consistent with persistent or intermittent asthma symptoms that include, but are not limited to;
- •dyspnea, wheezing, tightness in the chest, cough and sputum production.
- •The patient has a FEVi, while not using p-agonists for six hours, between 50% and 80% of the predicted value, documented at least twice during Visits 1, 2, and / or 3.
排除标准
- •In the opinion of the investigator, the patient is mentally or legally incapacitated, which prevents the informed consent from being obtained; He is unable to read.
- •The patient shows significant abnormalities in the physical examination of Visit 1 or in laboratory measurements.
- •The patient has a recent history (within 3 months of Visit 1) of
- •a clinically symptomatic psychiatric disorder.
研究者
相似试验
已完成
不适用
Study In People With Type 2 DiabetesPER-061-05GLAXOSMITHKLINE PERU S.A.,
已完成
不适用
TREATMENT OF PRIMARY GENERALIZED TONIC-CLONIC SEIZURES WITH AN INVESTIGATIONAL NEW DRUGPER-084-02GLAXOSMITHKLINE RESEARCH TRIANGLE PARK,
已完成
1 期
MULTICENTRIC, RANDOMIZED, DOUBLE-BLIND STUDY, WITH ACTIVE CONTROL, IN PARALLEL GROUPS, TO EVALUATE THE EFFICACY AND SAFETY OF VALSARTAN 320 MG COMPARED WITH VALSARTAN 160 MG IN HYPERTENSION PATIENTS-I10 Essential (primary) hypertensionEssential (primary) hypertensionI10PER-060-03OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
MULTICENTRIC, RANDOMIZED, DOUBLE-BLIND STUDY, IN PARALLEL GROUPS, WITH ACTIVE CONTROL, OF 24 WEEKS OF DURATION, TO EVALUATE THE EFFICACY OF THE COMBINATION VALSARTAN / HYDROCHLOROTHYAZIDE VERSUS AMLODIPINE ON THE SYSTOLIC ARTERIAL PRESSURE IN PATIENTS WITH MODERATE HYPERTENSION WITH RISK FACTORS AND / OR CARDIOVASCULAR CONCOMYANT DISEASE-I10 Essential (primary) hypertensionEssential (primary) hypertensionI10PER-010-03OVARTIS BIOSCIENSES PERU S.A.,
已完成
不适用
MULTICENTRIC STUDY DOUBLE BLIND, RANDOMIZED, PARALLEL, CONTROLLED WITH PLACEBO AND ACTIVE CONTROLLER TO EVALUATE THE EFFECTIVENESS AND SAFETY OF L-410198 IN THE ALTERATION OF LIPIDS IN PATIENTS THAT SUFFER FROM METABOLIC SYNDROME AND DYSLIPIDEMIASPER-020-02MERCK SHARP & DOHME PERU S.R.L.,